Baton Rouge Patient Completes Stage III Cancer Treatment
A local patient is celebrating the end of her treatment for Stage III breast cancer after tests showed no evidence of the disease.
Updated on Oct. 15, 2026 in Cancer
Michelle Guarisco, a Baton Rouge resident, has reached the end of her treatment for Stage III triple-negative breast cancer. Her recovery journey, which included both chemotherapy and a lumpectomy, was celebrated with a community parade at the Mary Bird Perkins Cancer Center.
Why it matters
Reaching the end of treatment for aggressive cancers like Stage III triple-negative breast cancer is a significant milestone for patients. Post-treatment evaluations such as the scans showing no evidence of disease are key components in the ongoing monitoring process for those in recovery.
Clinical follow-up assessments including post-treatment scans currently show no evidence of cancer for the patient. These results mark the conclusion of a treatment plan involving chemotherapy and a lumpectomy for a Stage III diagnosis, though long-term clinical data remain pending.
The players
Michelle Guarisco
A Baton Rouge resident who recently completed treatment for Stage III triple-negative breast cancer.
Mary Bird Perkins Cancer Center
A specialized oncology facility on Essen Lane providing comprehensive cancer care and treatment services.
Baton Rouge Corvette Club
A local automotive enthusiasts group that organized a parade featuring 18 decorated vehicles to support a local patient.
The details
Triple-negative breast cancer is an aggressive form of the disease that tests negative for estrogen, progesterone, and HER2 receptors. Treatment typically involves a multimodal approach, starting with systemic chemotherapy to reduce the tumor burden followed by surgical intervention such as a lumpectomy to remove the remaining localized mass. Successful completion of this regimen is marked by clinical follow-ups to monitor for any signs of residual disease.
Timeline
December 2025: Michelle Guarisco received her initial cancer diagnosis.
June 2026: The patient completed her chemotherapy sessions.
August 2026: A lumpectomy was performed to remove the tumor.
October 2026: The completion of all cancer treatments was celebrated.
Health Landscape
The clinical management of Stage III triple-negative breast cancer involves intensive standard-of-care protocols combining systemic therapy and surgery. This case highlights the established path from initial diagnosis to the conclusion of active treatment through this multi-step approach.
Patients undergoing treatment for breast cancer should prioritize consistent follow-up appointments and clear communication with their oncology team. Discuss any concerns regarding post-treatment surveillance and symptom monitoring with your primary care physician or oncologist.
The takeaway
Completing a rigorous cancer treatment plan is a major health milestone that warrants close coordination with your care team. Always maintain a regular schedule for follow-up imaging and exams as recommended by your physician to monitor your long-term health.
Further reading
For more information on the latest approaches to oncology, visit the Cancer section.
